Randomized Controlled Trials: Questions, Answers, and Musings: Second Edition

Randomized Controlled Trials: Questions, Answers, and Musings: Second Edition

Volumn , Issue , 2008, Pages 1-136

  Jadad, Alejandro R ^a,b,c   Enkin, Murray W ^b,d  

^a Centre for Global eHealth Innovation   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889305516     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691922     Document Type: Book

References (258)

1. Silverman WA, Chalmers I. Sir Austin Bradford Hill: an appreciation. Controlled Clinical Trials 1992;13:100-105.
2. Jadad AR, Rennie D. The randomized controlled trial gets a middle-aged checkup. Journal of American Medical Association 1998;279(4):319-320.
3. Altman DG. Practical Statistics for Medical Research, 2nd edition. London: Chapman & Hall, 2006.
4. Schulz KF. Subverting randomization in controlled trials. Journal of American Medical Association 1995;274:1456-1458.
5. Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149-153.
6. Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials in languages other than English: implications for the conduct and reporting of systematic reviews. Lancet 1996;347:363-366.
7. Mosteller F, Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials: agenda for the editor. Controlled Clinical Trials 1980;1:37-58.
8. Evans M, Pollock AV. Trials on trial: a review of trials of antibiotic prophylaxis. Archives of Surgery 1984;119:109-113.
9. Farrell B. Efficient management of randomized trials: nature or nurture. British Medical Journal 2006;317:1236-1239.
10. Norman GR, Streiner DL. Biostatistics: The Bare Essentials. Hamilton: Decker, 2000.
11. Smith R. The trouble with medical journals. London: Royal Society of Medicine Press, 2007.
12. Silverman WA. Gnosis and random allotment. Controlled Clinical Trials 1981;2:161-166.
13. Naylor CD. Grey zones of clinical practice: some limits to evidencebased medicine. Lancet 1995;345:840-842.
14. Freemantle N. Dealing with uncertainty: will science solve the problem of resource allocation in the UK NHS? Social Sciences and Medicine 1995;40:1365-1370.
15. Hill AB. Heberden Oration 1965:reflections on the controlled trial. Annals of Rheumatic Diseases 1965;25:107-113.
16. Horton R. The clinical trial: deceitful, disputable, unbelievable, unhelpful, and shameful-what next? Controlled Clinical Trials 2001;22:593-604.
17. Smith R. Medical journals and pharmaceutical companies: uneasy bedfellows. British Medical Journal 2003;326:1202-1205.
18. Angell M. The Truth About the Drug Companies: How They Deceive Us and What to Do about It, 1st edition. New York: Random House. 2004.
19. Kassirer JP. On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health. USA: Oxford University Press, 2005.
20. Smith R. The Trouble with Medical Journals. Royal Society of Medicine Press. 2007.
21. Plsek PE, Greenhalgh T. The challenge of complexity in health care. British Medical Journal 2001;323:625-628.
22. www.healthandeverything.org (accessed December 22, 2006).
23. Fletcher RH, Fletcher SW. Clinical Epidemiology: The Essentials, 4th edition. Baltimore, MD: Lippincott Williams & Wilkins, 2005.
24. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. New England Journal of Medicine 1979;301:1410-1412.
25. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research, 4th edition. Oxford, UK: Blackwell Publishing Professional, 2001.
26. Pocock SJ. Clinical Trials: A Practical Approach. Chichester, UK: John Wiley & Sons, 1983.
27. Fontanarosa PB, Rennie D, DeAngelis CD. Postmarketing surveillance-lack of vigilance, lack of trust. Journal of American Medical Association 2004;292:2647-2650.
28. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A, PPP Collaborative Group. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003;26:3264-3272.
29. Louis TA, Lavori PW, Bailar III JC, Polansky M. Crossover and selfcontrolled designs in clinical research. In Medical Uses of Statistics, 2nd edition, JC Bailar III and M Frederick (Eds.). Boston: New England Medical Journal Publications, 1992, pp. 83-104.
30. Sibbald B, Roberts C. Understanding controlled trials: crossover trials. British Medical Journal 1998;316:1719-1720.
31. Senn S. Cross-over Trials in Clinical Research. Chichester, UK: John Wiley & Sons, 2002.
32. Roberts C, Sibbald B. Understanding controlled trials. Randomising groups of patients. British Medical Journal 1998;316:1898-1900.
33. Bland JM, Kerry SM. Trials randomized in clusters. British Medical Journal 1997;315:600-660.
34. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
35. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts RS, Pugsley S. Determining optimal therapy-randomized trials in individual patients. New England Journal of Medicine 1986;314:889-892.
36. Woods KL. Mega-trials and management of acute myocardial infarction. Lancet 1995;346:611-614.
37. Charlton BG. Mega-trials: methodological issues and clinical implications. Journal of the Royal College of Physicians of London 1995;29:96-100.
38. King et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review. Journal of American Medical Association 2005;293:1089-1099.
39. Zelen M. A new design for randomized clinical trials. New England Journal of Medicine 1979;300:1242-1245.
40. Olschewski M, Scheurlen H. Comprehensive cohort study: an alternative to randomized consent design in a breast preservation trial. Methods of Information in Medicine 1985;24:131-134.
41. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. British Medical Journal 1989;299:684-685.
42. Flood AB, Wennberg JE, Nease Jr RF, Fowler Jr FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Journal of General Internal Medicine 1996;11:342-349.
43. Sackett DL, Wennberg JE. Choosing the best research design for each question. British Medical Journal 1997;315:1636.
44. www.healthandeverything.org (accessed December 22, 2006).
45. Jadad AR, Rennie D. The randomized controlled trial gets a middleaged checkup. Journal of American Medical Association 1998;279:319-320.
46. http://www.wordreference.com/definition/bias (accessed December 22, 2006).
47. Webster's Third New International Dictionary, Unabridged. G&C Merriam Co, 1976.
48. Owen R. Reader bias. Journal of American Medical Association 1982;247:2533-2534.
49. Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine 1983;309:1359-1361.
50. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of American Medical Association 1995;273:408-412.
51. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996;347:363-366.
52. Schulz KF. Subverting randomization in controlled trials. Journal of American Medical Association 1995;274:1456-1458.
53. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Therapy. Statistics in Medicine 1989;8:441-454.
54. Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. British Medical Journal 1996;312:742-744.
55. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay DM. Assessing the quality of reports on randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 1996;17:1-12.
56. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. International Journal of Technology Assessment in Health Care 1996;12:195-208.
57. Freeman TB. Use of placebo surgery in controlled trials of a cellularbased therapy for Parkinson's disease. New England Journal of Medicine 1999;34:988-992.
58. Fries JF, Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Research and Therapy 2004;6:R250-R255.
59. Sackett DL, Wennberg JE. Choosing the best research design for each question: It's time to stop squabbling over the 'best' methods. British Medical Journal 1997;315:1636.
60. Lilford RJ, Braunholtz DA, Greenhalgh R, Edwards SJL. Trials and fast changing technologies: the case for tracker studies. British Medical Journal 2000;320;43-46.
61. Kotaska A. Inappropriate use of randomised trials to evaluate complex phenomena: case study of vaginal breech delivery. British Medical Journal 2004;329:1039-1042.
62. Martin G. Munchausen's statistical grid, which makes all trials significant. Lancet 1984;ii:1457.
63. Dickersin K. The existence of publication bias and risk factors for its occurrence. Journal of American Medical Association 1990;263:1385-1389.
64. Rennie D, Flanagin A. Publication bias-the triumph of hope over experience. Journal of American Medical Association 1992;267:411-412.
65. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Education Prevention 1997;9(Suppl A):15-21.
66. Smith R. Medical Journals are an extension of the marketing arm of pharmaceutical companies. http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020124 (accessed November 21, 2006)
67. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Journal of American Medical Association 1996;276:637-639.
68. Grimes DA. The 'CONSORT' guidelines for randomized controlled trials in Obstetrics and Gynecology. Obstetrics and Gynecology 2002;100:631-632.
69. Rennie D. How to report randomized controlled trials. The CONSORT statement. Journal of American Medical Association 1996;276:649.
70. Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment 2003;7:1-90.
71. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 1998;19:159-166.
72. Ioannidis JPA. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials: a survival analysis. Journal of American Medical Association 1998;279:281-286.
73. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. British Medical Journal 1997;315:640-645.
74. McNutt RA, Evans AT, Fletcher RH, Fletcher SW. The effects of blinding on the quality of peer review. A randomized trial. Journal of American Medical Association 1990;263:1371-1376.
75. Enkin MW, Jadad AR. Using anecdotal information in evidence-based health care: heresy or necessity? Annals of Oncology 1998;9:963-966.
76. Koren G, Klein N. Bias against negative studies in newspaper reports of medical research. Journal of American Medical Association 1991;266:1824-1826.
77. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Journal of American Medical Association 1999;282:1054-1060.
78. Hill CL, LaValley MP, Felson DT. Discrepancy between published report and actual conduct of randomized clinical trials. Journal of Clinical Epidemiology 2002;55:783-786.
79. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 3rd edition. Oxford: Oxford University Press, 2003.
80. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effect in controlled clinical trials. Journal of American Medical Association 1995;273:408-412.
81. Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine 1983;309:1359-1361.
82. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I. Therapy. Statistics in Medicine 1989;8:441-454.
83. Khan KS, Daya S, Jadad AR. The importance of quality of primary studies in producing unbiased systematic reviews. Archives of Internal Medicine 1996;156:661-666.
84. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Annals of Internal Medicine 1996;124:485-488.
85. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Family Practice 2001;18:565-568.
86. Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ. Association between industry funding and statistically significant proindustry findings in medical and surgical randomized trials. Canadian Medical Association Journal 2004;170:477-480.
87. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials 1995;16:62-73.
88. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, Pham B, Klassen TP. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technology Assessment 1999;3:1-98.
89. Jadad AR. Meta-analysis of randomized clinical trials in pain relief. D. Phil Thesis, University of Oxford, 1994.
90. Ohlsson A, Lacy JB. Quality assessments of randomized controlled trials: an evaluation by the Chalmers versus the Jadad method. 3rd Annual Cochrane Colloquium 1995:V9-V10.
91. Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, Laupacis A. Assessing the quality of randomized trials: reliability of the Jadad scale. Controlled Clinical Trials 1999;20:448-452.
92. Bhandari M, Richards RR, Sprague S, Schemitsch EH. Quality in the reporting of randomized trials in surgery: Is the Jadad scale reliable? Controlled Clinical Trials 2001;22:687-688.
93. Moher D, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-613.
94. Sindhu F, Carpenter L, Seers K. Development of a tool to rate the quality assessment of randomized controlled trials using a Delphi technique. Journal of Advanced Nursing 1997;25:1262-1268.
95. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Journal of Clinical Epidemiology 1998;51:1235-1241.
96. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Physical Therapy 2003;83:713-721.
97. Bhogal SK, Teasell RW, Foley NC, Speechley MR. The PEDro scale provides a more comprehensive measure of methodological quality than the Jadad scale in stroke rehabilitation literature. Journal of Clinical Epidemiology 2005;58:668-673.
98. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and nonrandomised studies of health care interventions. Journal of Epidemiology and Community Health 1998;52:377-384.
99. Berlin JA for the University of Pennsylvania Meta-analysis Blinding Study Group. Does blinding of readers affect the results of meta-analyses? Lancet 1997;350:185-186.
100. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. Journal of Clinical Epidemiology 1992;45:255-265.
101. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. International Journal of Technology Assessment in Health Care 1996;12:195-208.
102. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup D. Improving the quality of reporting of randomized controlled trials-the CONSORT statement. Journal of American Medical Association 1996;276:637-639.
103. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. British Medical Journal 1996;313:570-571.
104. Moher D, Altman DG, Schulz KF, Elbourne DR. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal 2004;171:349-350.
105. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Medical Journal of Australia 2006;185:263-267.
106. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup D. Improving the quality of reporting of randomized controlled trials-The CONSORT Statement. Journal of American Medical Association 1996;276(63):7-9.
107. Moher D, Jones A, Lepage L. CONSORT Group (Consolidated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Journal of American Medical Association 2001;285:1992-1995.
108. Moher D, Altman DG, Schulz KF, Elbourne DR. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal 2004;171:349-350.
109. Guyatt G, Rennie D. User's Guide to the Medical Literature: Essentials of Evidence-Based Clinical Practice. American Medical Association 2001.
110. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence Based Medicine: How to Practice and Teach EBM, 3rd edition. Edinburgh: Churchill Livingstone, 2005.
111. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Annals of Internal Medicine 1990;113:69-76.
112. Bailey, KR. Generalizing the results of randomized clinical trials. Controlled Clinical Trials 1994;15:15-23.
113. Altman DG. Comparability of randomized groups. Statistician 1985;34:125-136.
114. Richardson W, Wilson M, Nishikawa J, et al. The well-built clinical question: a key to evidence-based decisions. ACP Journal Club 1995;123:12-13.
115. Altman, DG. Practical Statistics for Medical Research, 2nd edition. UK: Chapman & Hall, 2006.
116. Norman GR, Streiner DL. PDQ Statistics, 3rd edition. Toronto: BC Decker, 2003.
117. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Medical Journal of Australia 2006;185:263-267.
118. Latour B. Science in Action: How to Follow Scientists and Engineers Through Society. Cambridge, MA: Harvard University Press, 1987.
119. Jadad AR, Enkin M. The new alchemy: transmuting information to knowledge in the electronic age. Canadian Medical Association Journal 2000;162:1826-1828.
120. Deshpande A, Jadad AR. Web 2.0:Could it help move the health system into the 21st century? Journal of Men's Health and Gender 2006;3:332-336.
121. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Medicine 2005;2:e138. doi:10.1371/journal.pmed.0020138.
122. Mulrow CD. Rationale for systematic reviews. In Systematic Reviews, I Chalmers and DG Altman (Eds.). London: BMJ Publishing Group, 1995, pp. 1-8.
123. Smith R. The trouble with medical journals. Journal of the Royal Society of Medicine 2006;99:115-119.
124. Jadad AR, Rennie D. The randomized controlled trial gets a middle-aged checkup. Journal of American Medical Association 1998;279(4):319-320.
125. Jadad AR, Carroll D, Moore RA, McQuay HJ. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66:239-246.
126. http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/AccessCochraneLibrary.html (accessed December 22, 2006).
127. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed (accessed December 22, 2006).
128. http://www.embase.com/search (accessed December 22, 2006).
129. Till JE, Phillips RA, Jadad AR. Finding Canadian cancer clinical trials on the Internet: an exploratory evaluation of online resources. Canadian Medical Association Journal 2003;168:1127-1129.
130. http://bmjupdates.mcmaster.ca/(accessed December 22, 2006)
131. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O, Peacock R. Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Social Science and Medicine 2005;61:417-430.
132. Mulrow CD. The medical review article: state of the science. Annals of International Medicine 1987;106:485-488.
133. McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Moher D, Mulrow CD. The medical review article revisited: has the science improved? Annals of Internal Medicine 1999;131:947-951.
134. Schmidt LM, Gotzsche PC. Of mites and men: reference bias in narrative review articles: a systematic review. Journal of Family Practice 2005;54:334-338.
135. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. New England Journal of Medicine 1992;327:248-254.
136. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Journal of American Medical Association 1992;268:240-248.
137. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Annals of International Medicine 1997;126:376-380.
138. Akobeng AK. Understanding systematic reviews and meta-analysis. Archives of Disease in Childhood 2005;90:845-848.
139. Felson DT. Bias in meta-analytic research. Journal of Clinical Epidemiology 1992;45:885-892.
140. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, Improving the quality of reports of meta-analyses of randomized controlled trials the QUOROM statement. Lancet 1999;354:1896-1900.
141. Oxman Ad, Guyatt GH. Validation of an index of the quality of review articles. Journal of Clinical Epidemiology 1991;44:1271-1278.
142. Jadad AR, McQuay HJ. Meta-analysis to evaluate analgesic interventions: a systematic qualitative review of their methodology. Journal of Clinical Epidemiology 1996;49:235-243.
143. Guyatt G, Rennie D. User's Guide to the medical literature: essentials of evidence-based clinical practice. Chicago: American Medical Association Press 2002.
144. Jadad AR, Cook D, Browman GP. When arbitrators disagree: a guide to interpreting discordant systematic reviews of health care interventions. Canadian Medical Association Journal 1997;156:1411-1416.
145. Hopayian K. The need for caution in interpreting high quality systematic reviews. British Medical Journal 2001;323:681-684.
146. Bailar III JC The promise and problems of meta-analysis. New England Journal of Medicine 1997;337:559-560.
147. Cappelleri JC, Ioannidis JPA, Schmid CH, de Ferranti SD, Aubert M, Chalmers TC, Lau J. Large trials vs meta-analysis of smaller trials: How do their results compare? Journal of American Medical Association 1996;276:1332-1338.
148. LeLorier J, Gregoire, G, Benhaddad A, Lapierre J, Derderian F. Discre pancies between meta-analyses and subsequent large randomized, controlled trials. New England Journal of Medicine 1997;337:536-542.
149. Villar J, Carroli G, Pelizan JM. Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995;345:772-776.
150. Ioannidis JPA, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. Journal of American Medical Association 1998;279:1089-1093.
151. Furukawa T. Meta-analyses and megatrials: neither is the infallible, universal standard. Evidence-Based Mental Health 2004;7:34-35.
152. Sackett DL. The Cochrane Collaboration. ACP Journal Club 1994;May/June:A-11.
153. Cochrane AL. 1931-1971:a critical review, with particular reference to the medical profession. London: Office of Health Economics, 1979.
154. Jadad AR, Haynes RB. The Cochrane Collaboration-Advances and challenges in improving evidence-based decision making. Medical Decision Making 1998;18:2-9.
155. Laupacis A. The Cochrane Collaboration-how is it progressing? Statistics in Medicine 2002;21:2815-2822.
156. Grimshaw J. So what has the Cochrane Collaboration ever done for us? A report card on the first 10 years. Canadian Medical Association Journal 2004;171:747-749.
157. http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME (accessed December 22, 2006).
158. http://www.cochrane.org (accessed December 22, 2006).
159. http://www.ahrq.gov/clinic/epc/(accessed December 22, 2006).
160. http://www.campbellcollaboration.org/(accessed December 22, 2006).
161. Davies P, Boruch R. The Campbell Collaboration. Does for public policy what cochrane does for health. British Medical Journal 2001;323:294-295.
162. Field MJ, Lohr KN (Eds.). Clinical Practice Guidelines: Directions for a New Program. Institute of Medicine, Washington, DC: National Academy Press, 1990.
163. Cook D, Giacomini M. The trials and tribulations of clinical practice guidelines. Journal of American Medical Association 1999;281:1950-1951.
164. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. Journal of American Medical Association 1999;281:1900-1905.
165. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Journal of American Medical Association 2002;287:612-617.
166. Browman GP, Levine MN, Mohide EA, Hayward RSA, Pritchard KI, Gafni A, Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. Journal of Clinical Oncology 1995;13:502-512.
167. www.guideline.gov (accessed December 18, 2006).
168. Ioannidis JP. Indirect comparisons: the mesh and mess of clinical trials. Lancet 2006;368:1470-1472.
169. Haynes RB, Sackett DL, Gray JRM, Cook DL, Guyatt GH. Transferring evidence from research into practice. 1. The role of clinical care research evidence in clinical decisions. ACP Journal Club 1996;125:A-14;
170. Evidence-Based Medicine 1996;1:196-198.
171. Enkin M, Jadad AR. Using anecdotal information in evidence-based decision-making: heresy or necessity. Annals of Oncology 1998;9:963-966.
172. Sacks H, Chalmers TC, Smith Jr H. Randomized versus historical controls for clinical trials. American Journal of Medicine 1982;72:233-240.
173. Altman DG. Practical Statistics for Medical Research, 2nd edition. London: Chapman & Hall, 2006.
174. Streiner DL, Norman GR. PDQ Epidemiology, 2nd edition. St. Louis: Mosby, 1997.
175. Sackett DL, Wennberg JE. Choosing the best research design for each question. British Medical Journal 1997;315:1636.
176. Patel A, Jaeschke R, Guyatt GH, Keller JL, Newhouse MT. Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. American Review of Respiratory Disease 1991;144:962-964.
177. Fossey E, Harvey C, McDermott F, Davidson L. Understanding and evaluating qualitative research. Australian and New Zealand Journal of Psychiatry 2002;36:717-732.
178. Dixon-Woods M, Shaw RL, Agarwal S, Smith JA. The problem of appraising qualitative research. Quality and Safety in Health Care 2004;13(3):223-225.
179. Pope C, Mays N. Reaching the parts that other methods cannot reach: an introduction to qualitative methods in health and health services research. British Medical Journal 1995;311:42-45.
180. Payne S. Selecting an approach and design in qualitative research. Palliative Medicine 1997;11:249-252.
181. Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Research in Nursing and Health 2000;23:246-255.
182. Greenhalgh T. Integrating qualitative research into evidence-based practice. Endocrinology and Metabolism Clinics of North America 2002;31:583-601.
183. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science 1974;185:1124-1131.
184. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O, Peacock R. Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Social Science and Medicine 2005;61:417-430.
185. Redelmeier DA, Rozin P, Kahneman D. Understanding patients' decisions: cognitive and emotional perspectives. Journal of American Medical Association 1993;270:72-76.
186. Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit and feedback to implement practice guidelines. Journal of American Medical Association 1991;265:2202-2207.
187. Guyatt G. Evidence-based medicine. ACP Journal Club (Annals of Internal Medicine) 1991;14(Suppl 2):A-16.
188. Sakala C, Corry MP. What is evidence-based health care? Journal of Midwifery and Women's Health 2001;46(3):127-128.
189. Jadad AR, Haynes RB. The Cochrane Collaboration-Advances and challenges in improving evidence-based decision making. Medical Decision Making 1998;18:2-9.
190. Atkins D, Kamerow D, Eisenberg GM. Evidence-based medicine at the Agency for Health Care Policy and Research. ACP Journal Club 1998;128:A-14-A-16.
191. Smith K. Evidence-based management in health care. In Scientific Basis of Health Service, M Peckham and R Smith (Eds.). London: BMJ Publishing Group, 1996, pp.92-98.
192. Ervin NE, Pierangeli LT. The concept of decisional control: building the base for evidence-based nursing practice. Worldviews on Evidence-Based Nursing 2005;2:16-24.
193. Bruce ML, Van Citters AD, Bartels SJ. Evidence-based mental health services for home and community. Psychiatric Clinics of North America 2005;28:1039-1060.
194. O'Connor TS. The search for truth: the case for evidence-based chaplaincy. Journal of Health Care Chaplaincy 2002;13:185-194.
195. Gray JAM. Evidence-Based Healthcare: How to Make Health Policy and Management Decisions. London: Churchill Livingstone, 1997.
196. Bowen S, Zwi AB. Pathways to 'evidence-informed' policy and practice: a framework for action. PLoS Medicine/Public Library of Science 2005;2:e166.
197. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. New York: Churchill Livingstone, 1997.
198. Norman GR, Shannon SI. Effectiveness of instruction in critical appraisal (evidence-based medicine) skills: a critical appraisal. Canadian Medical Association Journal 1998;158:177-181.
199. Sackett DL, Parkes J. Teaching critical appraisal: no quick fixes. Canadian Medical Association Journal 1998;158:203-204.
200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed (accessed December 22, 2006).
201. http://www.ncbi.nlm.nih.gov/entrez/query/static/clinical.shtml (accessed December 22, 2006).
202. http://www.jr2.ox.ac.uk/bandolier/(accessed December 22, 2006).
203. http://www.clinicalevidence.com/(accessed December 22, 2006).
204. http://www.hsls.pitt.edu/resources/documentation/sammedinfo.html (accessed December 22, 2006).
205. http://www.uptodate.com/(accessed December 22, 2006).
206. http://www.clinicalevidence.com/ceweb/resources/useful_links.jsp (accessed December 22, 2006).
207. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. Journal of American Medical Association 1992;268:2420-2425.
208. Shahar E. A Popperian perspective of the term 'evidence-based medicine'. Journal of Evaluation in Clinical Practice 1997;3:109-116.
209. Tonelli MR. The philosophical limits of evidence-based medicine. Academic Medicine 1998;73:1234-1240.
210. Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. Canadian Medical Association Journal 2000;163:837-841.
211. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. British Medical Journal 1996;312:71-72.
212. Guyatt G, Cook D, Haynes RB. Evidence-based medicine has come a long way; the second decade will be as exciting as the first. British Medical Journal 2004;329:990-991.
213. Eysenbach G, Jadad AR. Evidence-based patient choice and consumer health informatics in the Internet age. Journal of Medical Internet Research 2001;3(2):e19.
214. Cowley C. The dangers of medical ethics. Journal of Medical Ethics 2005;31:739-742.
215. Fried C. Medical Experimentation; Personal Integrity and Social Policy. Amsterdam: North Holland, 1974 (cited in Miller PB, Weijer C. Rehabilitating equipoise. Kennedy Institute of Ethics Journal 2003;13:93-118).
216. Ellis PM. Attitudes towards participation in randomized clinical trials in oncology: a review of the literature. Annals of Oncology 2000;11:939-945.
217. Fries JF, Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Research and Therapy 2004;6(3):R250-R255.
218. Freedman B. Equipoise and the ethics of clinical research. New England Journal of Medicine 1987;317:141-145.
219. Weijer C, Shapiro SH, Glass KC. Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial: for. British Medical Journal 2000;321:756-757.
220. Enkin M. Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial: against. British Medical Journal 2000;321:757-758.
221. Lilford RJ, Jackson J. Equipoise and the ethics of randomization. Journal of the Royal Society of Medicine 1995;88:552-559.
222. Light IJ, The consent form: a time for reassessment. Journal of Pediatrics 1998;132:567-568.
223. Tognoni G, Geraci E. Approaches to informed consent. Controlled Clinical Trials 1997;18:621-627.
224. Donnellan P, Smyth J. Informed consent and randomised trials. Journal of the Royal College of Surgeons of Edinburgh 2001;46:100-102.
225. Truog RD, Morris AH. Is informed consent always necessary for randomized controlled trials? New England Journal of Medicine 1999;340:804-807.
226. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. Journal of American Medical Association 2004;292:1593-1601.
227. Ashcroft RE, Chadwick DW, Clark SLR, Edwards RHT, Frith L, Hutton J. Implications of socio-cultural contests for the ethics of clinical trials. Health Technology Assessment 1997;1:1-67.
228. Ferguson PR. Patient's perceptions of information provided in clinical trials. Journal of Medical Ethics 2002;28:45-48.
229. Kodish E, Eder M, Noll RB, Ruccione K, Lange B, Angiolillo A, et al. Communication of randomization in childhood leukemia trials. Journal of American Medical Association 2004;291:470-475.
230. Edwards SJ, Lilford RJ, Hewison J. The ethics of randomised controlled trials from the perspectives of patients, the public, and health care professional. British Medical Journal 1998;317:1209-1212.
231. Melby T, Mendelson JE, Jones RT. Patients' understanding of consent form should be checked before participation in trial. British Medical Journal 1996;312:847.
232. Marcus EN. The silent epidemic-the health effects of illiteracy. New England Journal of Medicine 2006;355:339-341.
233. Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed consent forms as compared with actual readability. New England Journal of Medicine 2003;348:721-726.
234. Coyne CA, Xu R, Raich P, Plomer K, Dignam M, Wenzel LB, et al. Randomized controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 2003;21:836-842.
235. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. British Medical Journal 2002;325:766-769.
236. Mason V, McEwan A, Walker D, et al. The use of video information in obtaining consent for female sterilization: a randomised study. British Journal of Obstetrics and Gynaecology 2003;110:1062-1071.
237. Wager E, Tooley PJH, Emanuel MB, Wood SF. How to do it: get patients' consent to enter clinical trials. British Medical Journal 1995;311:734-737.
238. Habiba M, Evans M. The inter-role confidentiality conflict in recruitment for clinical research. Journal of Medicine and Philosophy 2002;27:565-587.
239. Ilitis AS. Timing invitations to participate in clinical research: preliminary versus informed consent. Journal of Medicine and Philosophy 2005;30:89-106.
240. Rogers CG, Tyson JE, Kennedy KA, Broyles S, Hickman J. Conventional consent with opting in versus simplified consent with opting out: an exploratory trial for studies that do not increase patient risk. Journal of Pediatrics 1998;132:606-611.
241. Junghans C, Feder G, Hemingway H, Timmis A, Jones M. Recruiting patients to medical research: double blind randomised trial of 'opt-in' versus 'opt-out' strategies. British Medical Journal 2005;331:940.
242. Allmark P, Mason S. Improving the quality of consent to randomized controlled trials by using continuous consent and clinician training in the consent process. Journal of Medical Ethics 2006;32:439-443.
243. Heaven B, Murtagh M, Rapley T, May C, Graham R, Kaner E, Thomson R. Patients or research subjects? A qualitative study of participation in a randomised controlled trial of a complex intervention. Patient Education and Counseling 2006;62:260-270.
244. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. New England Journal of Medicine 1994;331:394-398.
245. Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Annals of Internal Medicine 2002;136:817-825.
246. Skovlund E. Should we tell trial patients that they might receive a placebo? Lancet 1991;337:1041.
247. Baer N. Debate about placebos points to issue surrounded by many shades of grey. Canadian Medical Association Journal 1996;155:1475-1476.
248. Angell M. The ethics of clinical research in the third world. New England Journal of Medicine 1997;337:847-849.
249. Brody BA. Ethical issues in clinical trials in developing countries. Statistics in Medicine 2002;21:2853-2858.
250. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine 1997;337:853-856.
251. McLeod RS, Wright JG, Solomon MJ, Hu X, Walters BC, Lossing AI. Randomized controlled trials in surgery: issues and problems. Surgery 1996;119:483-486.
252. Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal-mammary-artery ligation by a double-blind technic. New England Journal of Medicine 1959;260:1115-1118.
253. Macklin E. The ethical problems with sham surgery in clinical research. New England Journal of Medicine 1999;341:992-996.
254. Enkin MW. The need for evidence-based obstetrics. Evidence-Based Medicine 1996;1:132-133.
255. McCullough LB, Coverdale JH, Chervenak FA. A comprehensive ethical framework for responsibly designing and conducting pharmacologic research that involves pharmacologic research that involves pregnant women. American Journal of Obstetrics and Gynecology 2005;193:901-907.
256. Edwards SJL, Braunholtz DA, Lilford RJ. Ethical issues in the design and conduct of cluster randomized controlled trials. British Medical Journal 1999;318:1407-1409.
257. Hutton JL. Are distinctive ethical principles required for cluster randomized controlled trials? Statistics in Medicine 2001;20:473-488.
258. Bryant J, Powell J. Payment to healthcare professionals for patient recruitment to trials: a systematic review. British Medical Journal 2005;331:1377-1378.